FDA Approves RSV Vaccine Abrysvo for Use During Pregnancy to Protect Infants
Abyrsvo is the first vaccine approved for pregnant individuals to prevent RSV disease in infants.
Abyrsvo is the first vaccine approved for pregnant individuals to prevent RSV disease in infants.
The investigational therapy is designed to decrease the production of soluble fms-like tyrosine kinase-1 (sFLT1) mRNA isoforms in the placenta.
Removing the prescription requirement improves access to an effective contraceptive method for women of all ages.
Timely recognition and treatment of postpartum preeclampsia is essential to improving morbidity and mortality in postpartum patients.
Studies link chlamydia to a high risk of female infertility. How should primary care providers assess for inflammation and tubal patency in affected patients?
Veozah is an oral neurokinin 3 (NK3) receptor antagonist.
A decision on the OTC oral contraceptive pill is expected later this year.
CMS investigates 2 hospitals for EMTALA violations related to abortion care for a pregnancy-related emergency.
If approved, Opill would be the first daily oral contraceptive pill available without a prescription.
The conversion to regular approval was based on data from an additional 141 patients with dMMR recurrent or advanced endometrial cancer who had progressed on or after a platinum-containing regimen.